臺灣健保癌症用藥事前審查實作指引
1.0.1 - release

This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: LOINC-健保事前審查-基因突變類型值集

Official URL: https://twcore.mohw.gov.tw/ig/pas/ValueSet/dna-change-type Version: 1.0.1
Active as of 2024-12-06 Computable Name: DNAChangeType

LOINC-健保事前審查-基因突變類型值集

References

Logical Definition (CLD)

Generated Narrative: ValueSet dna-change-type

This value set includes codes based on the following rules:

 

Expansion

Generated Narrative: ValueSet

This value set contains 10 concepts

CodeSystemDisplay
  LA6692-3http://loinc.orgDeletion
  LA6686-5http://loinc.orgDuplication
  LA6687-3http://loinc.orgInsertion
  LA6688-1http://loinc.orgInsertion/Deletion
  LA6689-9http://loinc.orgInversion
  LA6690-7http://loinc.orgSubstitution
  101397-8http://loinc.orgCopy number variation analysis in Blood or Tissue by Sequencing
  81695-9http://loinc.orgMicrosatellite instability [Interpretation] in Cancer specimen Qualitative
  94077-5http://loinc.orgTumor mutation burden [Interpretation]
  O55-2https://twcore.mohw.gov.tw/ig/pas/CodeSystem/inca-osirisDelins

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code